|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-9-28
|
|
pubmed:abstractText |
A pharmacokinetic comparison of three dosing regimens of saquinavir/ritonavir was carried out: 1600/100 mg once-daily with 1000/100 mg twice-daily, and 1600/100 mg once-daily with 2000/100 mg once-daily.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
pubmed-author:AnanworanichJJ,
pubmed-author:ApateerapongWW,
pubmed-author:AutarR SRS,
pubmed-author:BurgerDD,
pubmed-author:CooperDD,
pubmed-author:HillAA,
pubmed-author:HirschelBB,
pubmed-author:LangeJJ,
pubmed-author:PhanuphakPP,
pubmed-author:RuxrungthamKK,
pubmed-author:SankoteJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
785-90
|
|
pubmed:meshHeading |
pubmed-meshheading:15329366-Adult,
pubmed-meshheading:15329366-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15329366-Capsules,
pubmed-meshheading:15329366-Drug Administration Schedule,
pubmed-meshheading:15329366-Female,
pubmed-meshheading:15329366-Gels,
pubmed-meshheading:15329366-HIV Infections,
pubmed-meshheading:15329366-HIV-1,
pubmed-meshheading:15329366-Humans,
pubmed-meshheading:15329366-Male,
pubmed-meshheading:15329366-Metabolic Clearance Rate,
pubmed-meshheading:15329366-Ritonavir,
pubmed-meshheading:15329366-Saquinavir
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.
|
|
pubmed:affiliation |
The HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Center, Bangkok, Thailand. saskia@hivnat.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
